galectin-9 (sgal-9) (Galectin Therapeutics)
90
Structured Review
Galectin Therapeutics
galectin-9 (sgal-9)
Galectin 9 (Sgal 9), supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9+(sgal-9)/galectin+9/pm36706838-176-4-6
Average 90 stars, based on 1 article reviews
Galectin 9 (Sgal 9), supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9+(sgal-9)/galectin+9/pm36706838-176-4-6
Average 90 stars, based on 1 article reviews
galectin-9 (sgal-9) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Immunopeptidomics:Article Title: sMICA/sMICB and Immune Checkpoint in Endometriosis: Toward a Minimally Invasive Diagnostic Model Based on Machine Learning Article Snippet: .. Therefore, this study aimed to evaluate the levels of soluble immune checkpoints and mediators: sMICA (MHC class I Chain-related A), sMICB (MHC class I Chain-related B), sEng (Endoglin), sCD25, s4-1BB, sB7.2 (CD86/B7.2), sCTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4), sPD-L1 (Programmed Death-Ligand 1), sPD-1, sTIM-3 (T cell Immunoglobulin and Mucin domaincontaining protein 3), sLAG-3 (Lymphocyte Activation Gene-3), and Activation Assay:Article Title: sMICA/sMICB and Immune Checkpoint in Endometriosis: Toward a Minimally Invasive Diagnostic Model Based on Machine Learning Article Snippet: .. Therefore, this study aimed to evaluate the levels of soluble immune checkpoints and mediators: sMICA (MHC class I Chain-related A), sMICB (MHC class I Chain-related B), sEng (Endoglin), sCD25, s4-1BB, sB7.2 (CD86/B7.2), sCTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4), sPD-L1 (Programmed Death-Ligand 1), sPD-1, sTIM-3 (T cell Immunoglobulin and Mucin domaincontaining protein 3), sLAG-3 (Lymphocyte Activation Gene-3), and other:Article Title: Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery. Article Snippet: Mesenchymal stromal/stem cells (MSCs) perform their therapeutic effects through various mechanisms, including their ability to differentiate, producing different growth factors, immunomodulatory factors, and extracellular vesicles (EVs).. In addition to the mentioned mechanisms, a new aspect of the therapeutic potential of MSCs has recently been noticed, which occurs through mitochondrial transfer.. Various methods of MSCs mitochondria transfer have been used in studies to benefit from their therapeutic potential. Article Title: Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis Article Snippet: Serum levels of soluble programmed death ligand 1 (sPD-L1), soluble T-cell immunoglobulin- and mucin-domain–containing Article Title: A review of alcohol-pathogen interactions: New insights into combined disease pathomechanisms. Article Snippet: Soluble CRS, namely Tim3 (sTim- 3) and its ligands |